🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the EU / 2026-525682-45-00
Authorised Phase IV

Efficacy of oral bicarbonate versus placebo on the risk of assisted delivery in nulliparous women with prolonged labour (ProLabour): protocol fora randomized controlled trial

2026-525682-45-00 · tracked via the Priya Life Science EU tracker
Sponsor type
Hospital/Clinic/Other health care facility
Therapeutic area
Female Urogenital Diseases and Pregnancy Complications
Decision date
14/07/2026
Enrollment target
1520
Sites
Denmark

Condition studied

Prolonged labour

Investigational medicinal product(s)

The placebo contains only inert excipients (glucose 3 gsodium chloride 0,65 gsilica 0,05 g) and a flavouring agent (aromalemon–peachfood-grade excipient).Samarin

Eligibility

Age group
18-64 years
Sex
Female

Primary endpoint

The primary endpoint is the incidence of assisted delivery, defined as a composite of emergency caesarean section or instrumental vaginal delivery.

Endpoint detail

Admission of the child to the neonatal intensive care unit within 24 hours after birth. Birth experience (The Childbirth Experience Questionnaire).

Official registry record

This page summarises publicly available CTIS data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View 2026-525682-45-00 on CTIS ↗ ← All trials in the EU